| pubmed-article:19385735 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0016627 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0018909 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0027803 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:19385735 | lifeskim:mentions | umls-concept:C1546857 | lld:lifeskim |
| pubmed-article:19385735 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:19385735 | pubmed:dateCreated | 2009-5-12 | lld:pubmed |
| pubmed-article:19385735 | pubmed:abstractText | Hemagglutination-inhibition (HI) antibody titers correlate with protective immunity to seasonal influenza viruses. However, inactivated H5N1 influenza vaccines from Vietnam 2004 strains afford protection without producing high or even detectable HI antibodies. | lld:pubmed |
| pubmed-article:19385735 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19385735 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19385735 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19385735 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19385735 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19385735 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19385735 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19385735 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19385735 | pubmed:issn | 0022-1899 | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:HasegawaHidek... | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:SataTetsutaro... | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:KobayashiKazu... | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:NinomiyaAiA | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:TashiroMasato... | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:AtoManabuM | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:TakahashiYosh... | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:OdagiriTakato... | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:HaraYukariY | lld:pubmed |
| pubmed-article:19385735 | pubmed:author | pubmed-author:TakagiHirotak... | lld:pubmed |
| pubmed-article:19385735 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19385735 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:19385735 | pubmed:volume | 199 | lld:pubmed |
| pubmed-article:19385735 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19385735 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19385735 | pubmed:pagination | 1629-37 | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:meshHeading | pubmed-meshheading:19385735... | lld:pubmed |
| pubmed-article:19385735 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19385735 | pubmed:articleTitle | Protective immunity afforded by inactivated H5N1 (NIBRG-14) vaccine requires antibodies against both hemagglutinin and neuraminidase in mice. | lld:pubmed |
| pubmed-article:19385735 | pubmed:affiliation | Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan. ytakahas@nih.go.jp | lld:pubmed |
| pubmed-article:19385735 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19385735 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19385735 | lld:pubmed |
